What Does Infinitus Think About the Relationship Between AI Automation and Human Oversight?

In a conversation with Pharmaceutical Executive, Ankit Jain, CEO, Co-Founder, Infinitus discusses how Infinitus is reimagining patient access through AI, aiming to streamline the patient journey from diagnosis to therapy adherence. Jain notes how Infinitus focuses on reducing friction points like prior authorization and benefit verification, leveraging AI to handle repetitive tasks and empower care teams to provide empathetic care.

A transcript of Jain’s conversation with Pharmaceutical Executive can be found below.

Pharmaceutical Executive: You're presenting at Access USA later today, what do you hope audience members walk away thinking about after your session
Ankit Jain: I'm really excited for the talk later today, where we're going to talk about how most groups are using their people the wrong way most people, most groups, are using their people to do work that AI can do while they have to because of a lack of resources, neglect the work that really gets the patient that empathetic care at a time of extreme need.

So what we're going to try to do is to flip the script on its head and go imagine a world where AI took care of a lot of the repetitive, tedious, formulaic work, whether it's benefit verifications, whether it's a welcome call, whether it's collecting missing information touching all the different parts of the ecosystems, the payers, the patients, the HCPs, so that those case managers, those patient navigators, can really be present for those patients, their caregivers, and make them feel supported through their journey.

PE: What does Infinitus think about the relationship between AI automation and human oversight?
Jain: Well, there's a lot that goes into earning trust from healthcare organizations looking to use AI. No one wants to be the first one to adopt a new technology. Everyone wants to be number three. The first one proved it. The second one proved that it could be repeatable and the third one’s safe.

Well, at Infinitus, we've been very lucky that we've been doing this for the last seven years. We've done over 100 million minutes of autonomous conversations. And not only are we autonomously completing tasks getting patients on therapy faster than ever before, but with the AI based oversight of those of those systems, now these systems don't work in isolation. They work side by side with humans.

Our thesis is that humans and AI need to work together. Humans give the oversight to the AI to make sure it keeps moving forward, and then when the humans are handling other things, the AI continues to move the process forward.

This is the way patients can get on therapy faster. HCPs don't have less frustration, and pharmaceutical manufacturers can see their drugs actually have the impact that they always promise to have.